Bioheart's Unattributed VC - III Round

Bioheart raised a round of funding on March 31, 2011.

Bioheart is a biotechnology company focused on the discovery, development, and commercialization of cell therapies for the treatment of chronic and acute heart damage.…

Articles about Bioheart's Unattributed VC - III Round: